These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22941955)

  • 1. Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model.
    Aparicio-Vergara M; Hommelberg PP; Schreurs M; Gruben N; Stienstra R; Shiri-Sverdlov R; Kloosterhuis NJ; de Bruin A; van de Sluis B; Koonen DP; Hofker MH
    Hepatology; 2013 Feb; 57(2):566-76. PubMed ID: 22941955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
    Lambertucci F; Arboatti A; Sedlmeier MG; Motiño O; Alvarez ML; Ceballos MP; Villar SR; Roggero E; Monti JA; Pisani G; Quiroga AD; Martín-Sanz P; Carnovale CE; Francés DE; Ronco MT
    J Nutr Biochem; 2018 Aug; 58():17-27. PubMed ID: 29860102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.
    Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
    J Nutr Biochem; 2011 Jun; 22(6):527-34. PubMed ID: 20801629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFα gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice.
    Salles J; Tardif N; Landrier JF; Mothe-Satney I; Guillet C; Boue-Vaysse C; Combaret L; Giraudet C; Patrac V; Bertrand-Michel J; Denis P; Chardigny JM; Boirie Y; Walrand S
    J Nutr Biochem; 2012 Dec; 23(12):1685-93. PubMed ID: 22464148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.
    Xu E; Forest MP; Schwab M; Avramoglu RK; St-Amand E; Caron AZ; Bellmann K; Shum M; Voisin G; Paquet M; Montoudis A; Lévy E; Siminovitch KA; Neel BG; Beauchemin N; Marette A
    Hepatology; 2014 May; 59(5):1803-15. PubMed ID: 24327268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
    Imajo K; Fujita K; Yoneda M; Nozaki Y; Ogawa Y; Shinohara Y; Kato S; Mawatari H; Shibata W; Kitani H; Ikejima K; Kirikoshi H; Nakajima N; Saito S; Maeyama S; Watanabe S; Wada K; Nakajima A
    Cell Metab; 2012 Jul; 16(1):44-54. PubMed ID: 22768838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
    Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids.
    D'souza AM; Beaudry JL; Szigiato AA; Trumble SJ; Snook LA; Bonen A; Giacca A; Riddell MC
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G850-63. PubMed ID: 22268100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
    Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for nonalcoholic steatohepatitis.
    Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
    J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
    Matsuzawa N; Takamura T; Kurita S; Misu H; Ota T; Ando H; Yokoyama M; Honda M; Zen Y; Nakanuma Y; Miyamoto K; Kaneko S
    Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver.
    Ashino NG; Saito KN; Souza FD; Nakutz FS; Roman EA; Velloso LA; Torsoni AS; Torsoni MA
    J Nutr Biochem; 2012 Apr; 23(4):341-8. PubMed ID: 21543214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.
    Legry V; Van Rooyen DM; Lambert B; Sempoux C; Poekes L; Español-Suñer R; Molendi-Coste O; Horsmans Y; Farrell GC; Leclercq IA
    Clin Sci (Lond); 2014 Oct; 127(7):507-18. PubMed ID: 24766485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability.
    Li J; Sapper TN; Mah E; Moller MV; Kim JB; Chitchumroonchokchai C; McDonald JD; Bruno RS
    J Nutr Biochem; 2017 Mar; 41():34-41. PubMed ID: 28038359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease.
    Kim EH; Bae JS; Hahm KB; Cha JY
    Biochem Pharmacol; 2012 Nov; 84(10):1359-65. PubMed ID: 22981383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.